Passion Pit's Michael Angelakos Reflects On Bipolar Disorder And New Album 'kindred' | Billboard

NASCARs waiver rule frees drivers to chase titles, preserve health | The Courier-Tribune

My brain is always going, and when Im here, just knowing I can access that energy, makes me feel not so crazy. Skrillex & Diplo's 'Jack U' Debuts at No. 1 on Top Dance/Electronic Albums After the fallout from the last record, how did you handle your mental state this time around? For the original version including any supplementary images or video, visit

Horizon Pharma plc Announces Settlement of PENNSAID(R) 2% Patent Litigation With Perrigo Company plc - Yahoo Finance

According to an estimate from the National Cancer Institute ,in 2012 alone, more than 52,000 men and women were diagnosed with head and neck cancers in the United States. Realizing the risks The reality is, the risk for head and neck cancer is present in more Americans than you might think, particularly those of us who smoke and drink alcohol, the two biggest risk factors for head and neck cancers of the mouth, oropharynx, hypopharynx and larynx. In fact, at least 75 percent of head and neck cancers are caused by tobacco and alcohol use, according to the National Cancer Institute. However, environmental exposures may also play a role. For instance, individuals working in some jobs in the construction, textile, ceramic, wood and metal industries could have an increased risk of paranasal sinus and nasal cavity cancer. Exposure to smoking and Epstein Barr Virus (EBV) how to treat sinus infection is a risk factor for nasopharyngeal cancer, while certain other industrial exposures, like asbestos and synthetic fibers, have been linked to larynx cancer. [ Smoking Causes 14 Million Medical Conditions in US Yearly, Study Finds ] Human papillomavirus virus (HPV) is also a big risk factor for some kinds of head and neck cancers, specifically ones that involve the tonsils or base of the tongue. In fact, a large amount of oropharyngeal cancers, even reaching back 40 years, have actually been from HPV-positive tumors. Today in the United States, cancers caused by HPV infection are rising while cancers caused by smoking are falling. Additionally, sun exposure to the head and neck is a risk factor for skin cancers, and genetics can also play a role. For the original version including any supplementary images or video, visit

Deadly, Lesser-Known Head and Neck Cancers Can't be Ignored (Op-Ed) - Yahoo News

They would sometimes start a race and then turn to a relief driver, thus pocketing the points. Others tried to tough it out, a questionable decision for long-term health. And this wasnt some bygone era. For the original version including any supplementary images or video, visit

WASHINGTON: Walk-in clinics bring affordable, on-demand health care to the masses | Health Care | McClatchy DC

Theyre filled up for the episodic stuff already. They cant get patients in immediately. So were just serving as an extension of their office while (freeing up) the emergency departments to take care of the more acute needs. With a national shortage of doctors, higher rates of chronic illness and more people with health insurance under the Affordable Care Act , its no surprise that walk-in clinics are booming. For the original version including any supplementary images or video, visit

District Court for the District of New Jersey and the U.S. District Court for the District of Delaware relating to the ANDA filed by Perrigo with the U.S. Food and Drug Administration for a generic version of PENNSAID 2%. Details of the settlement are confidential and the agreement is subject to submission to the Federal Trade Commission and the U.S. Department of Justice. "This settlement further validates the innovation of PENNSAID 2% and the strength of our patent estate," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc. "We will continue to vigorously defend patent challenges in order to protect our innovation and ensure continued patient access." About PENNSAID 2% PENNSAID (diclofenac sodium topical solution) 2% w/w is a non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of pain of osteoarthritis (OA) of the knee(s).PENNSAID 2% contains diclofenac sodium, an NSAID, and also includes dimethyl sulfoxide (DMSO), a powerful penetrating agent that helps ensure that diclofenac sodium is absorbed through the skin to the site of inflammation and pain.PENNSAID 2% is an alternative to oral NSAID treatment, reducing systemic exposure to a fraction of that provided by the oral NSAID diclofenac.The only topical NSAID offered with the convenience of picture of sinus infection a metered-dose pump, PENNSAID 2% is applied in two pumps, twice daily, to the site of OA knee pain.For more information, please see For the original version including any supplementary images or video, visit